Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones.

Luethi D, Walter M, Zhou X, Rudin D, Krähenbühl S, Liechti ME.

Front Pharmacol. 2019 Apr 24;10:438. doi: 10.3389/fphar.2019.00438. eCollection 2019.

2.

Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).

Luethi D, Widmer R, Trachsel D, Hoener MC, Liechti ME.

Eur J Pharmacol. 2019 Jul 15;855:103-111. doi: 10.1016/j.ejphar.2019.05.014. Epub 2019 May 4.

PMID:
31063768
3.

Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.

Luethi D, Kolaczynska KE, Walter M, Suzuki M, Rice KC, Blough BE, Hoener MC, Baumann MH, Liechti ME.

J Psychopharmacol. 2019 Jul;33(7):831-841. doi: 10.1177/0269881119844185. Epub 2019 Apr 30.

PMID:
31038382
4.

Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.

Luethi D, Hoener MC, Krähenbühl S, Liechti ME, Duthaler U.

Biochem Pharmacol. 2019 Jun;164:129-138. doi: 10.1016/j.bcp.2019.04.013. Epub 2019 Apr 11.

PMID:
30981875
5.

Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts.

Zhou X, Luethi D, Sanvee GM, Bouitbir J, Liechti ME, Krähenbühl S.

Int J Mol Sci. 2019 Mar 28;20(7). pii: E1561. doi: 10.3390/ijms20071561.

6.

Stereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter.

Mayer FP, Cintulova D, Pittrich DA, Wimmer L, Luethi D, Holy M, Jaentsch K, Tischberger S, Gmeiner G, Hoener MC, Liechti ME, Mihovilovic MD, Sitte HH.

Neuropharmacology. 2019 Apr;148:199-209. doi: 10.1016/j.neuropharm.2018.12.032. Epub 2019 Jan 2.

PMID:
30610839
7.

The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.

Maier J, Mayer FP, Luethi D, Holy M, Jäntsch K, Reither H, Hirtler L, Hoener MC, Liechti ME, Pifl C, Brandt SD, Sitte HH.

Neuropharmacology. 2018 Aug;138:282-291. doi: 10.1016/j.neuropharm.2018.06.018. Epub 2018 Jun 23.

8.
9.

Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems.

Luethi D, Hoener MC, Liechti ME.

Eur J Pharmacol. 2018 Jan 15;819:242-247. doi: 10.1016/j.ejphar.2017.12.012. Epub 2017 Dec 7.

PMID:
29225192
10.

Pharmacological profile of methylphenidate-based designer drugs.

Luethi D, Kaeser PJ, Brandt SD, Krähenbühl S, Hoener MC, Liechti ME.

Neuropharmacology. 2018 May 15;134(Pt A):133-140. doi: 10.1016/j.neuropharm.2017.08.020. Epub 2017 Aug 18.

PMID:
28823611
11.

Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers.

Dhayat NA, Gradwell MW, Pathare G, Anderegg M, Schneider L, Luethi D, Mattmann C, Moe OW, Vogt B, Fuster DG.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1507-1517. doi: 10.2215/CJN.01320217. Epub 2017 Aug 3.

12.

Pharmacological profile of mephedrone analogs and related new psychoactive substances.

Luethi D, Kolaczynska KE, Docci L, Krähenbühl S, Hoener MC, Liechti ME.

Neuropharmacology. 2018 May 15;134(Pt A):4-12. doi: 10.1016/j.neuropharm.2017.07.026. Epub 2017 Jul 26.

PMID:
28755886
13.

Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).

Luethi D, Trachsel D, Hoener MC, Liechti ME.

Neuropharmacology. 2018 May 15;134(Pt A):141-148. doi: 10.1016/j.neuropharm.2017.07.012. Epub 2017 Jul 15.

PMID:
28720478
14.

Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.

Luethi D, Liechti ME, Krähenbühl S.

Toxicology. 2017 Jul 15;387:57-66. doi: 10.1016/j.tox.2017.06.004. Epub 2017 Jun 20.

PMID:
28645576
15.

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).

Rickli A, Luethi D, Reinisch J, Buchy D, Hoener MC, Liechti ME.

Neuropharmacology. 2015 Dec;99:546-53. doi: 10.1016/j.neuropharm.2015.08.034. Epub 2015 Aug 25.

PMID:
26318099
16.

Liquid chromatography-tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma.

Luethi D, Durmus S, Schinkel AH, Schellens JH, Beijnen JH, Sparidans RW.

Biomed Chromatogr. 2014 Oct;28(10):1366-70. doi: 10.1002/bmc.3176. Epub 2014 Mar 12.

PMID:
24619951
17.

Liquid chromatography-tandem mass spectrometry assay for the EGFR inhibitor pelitinib in plasma.

Luethi D, Durmus S, Schinkel AH, Schellens JH, Beijnen JH, Sparidans RW.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:22-5. doi: 10.1016/j.jchromb.2013.06.030. Epub 2013 Jul 4.

PMID:
23892825
18.

Orbital and millennial Antarctic climate variability over the past 800,000 years.

Jouzel J, Masson-Delmotte V, Cattani O, Dreyfus G, Falourd S, Hoffmann G, Minster B, Nouet J, Barnola JM, Chappellaz J, Fischer H, Gallet JC, Johnsen S, Leuenberger M, Loulergue L, Luethi D, Oerter H, Parrenin F, Raisbeck G, Raynaud D, Schilt A, Schwander J, Selmo E, Souchez R, Spahni R, Stauffer B, Steffensen JP, Stenni B, Stocker TF, Tison JL, Werner M, Wolff EW.

Science. 2007 Aug 10;317(5839):793-6. Epub 2007 Jul 5.

Supplemental Content

Loading ...
Support Center